Joshua Pinto - Net Worth and Insider Trading

Joshua Pinto Net Worth

The estimated net worth of Joshua Pinto is at least $494,450 dollars as of 2025-07-25. Joshua Pinto is the President of Neumora Therapeutics Inc and owns about 215,917 shares of Neumora Therapeutics Inc (NMRA) stock worth over $494,450. Details can be seen in Joshua Pinto's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua Pinto has not made any transactions after 2025-02-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Joshua Pinto

To

Joshua Pinto Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua Pinto owns 1 companies in total, including Neumora Therapeutics Inc (NMRA) .

Click here to see the complete history of Joshua Pinto’s form 4 insider trades.

Insider Ownership Summary of Joshua Pinto

Ticker Company Transaction Date Type of Owner
NMRA Neumora Therapeutics Inc 2025-02-18 Chief Financial Officer

Joshua Pinto Latest Holdings Summary

Joshua Pinto currently owns a total of 1 stock. Joshua Pinto owns 215,917 shares of Neumora Therapeutics Inc (NMRA) as of February 18, 2025, with a value of $494,450.

Latest Holdings of Joshua Pinto

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NMRA Neumora Therapeutics Inc 2025-02-18 215,917 2.29 494,450

Holding Weightings of Joshua Pinto


Joshua Pinto Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua Pinto has made a total of 3 transactions in Neumora Therapeutics Inc (NMRA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Neumora Therapeutics Inc is the sale of 8,048 shares on February 18, 2025, which brought Joshua Pinto around $13,440.

Insider Trading History of Joshua Pinto

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua Pinto Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joshua Pinto Ownership Network

Ownership Network List of Joshua Pinto

No Data

Ownership Network Relation of Joshua Pinto

Insider Network Chart


Joshua Pinto Owned Company Details

What does Neumora Therapeutics Inc do?

Who are the key executives at Neumora Therapeutics Inc?

Joshua Pinto is the Chief Financial Officer of Neumora Therapeutics Inc. Other key executives at Neumora Therapeutics Inc include See Remarks Michael Lee Milligan , Head of R&D Robert A. Lenz , and Chief Strategy Officer Daljit Singh Aurora .

Neumora Therapeutics Inc (NMRA) Insider Trades Summary

Over the past 18 months, Joshua Pinto made 3 insider transaction in Neumora Therapeutics Inc (NMRA) with a net sale of 108,048. Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net sale of 93,849 shares made by Robert A. Lenz , a net sale of 21,788 shares made by Matthew K Fust , and a net sale of 13,871 shares made by Paul L Berns .

In summary, during the past 3 months, insiders sold 0 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 248,099 shares of Neumora Therapeutics Inc (NMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 248,099 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neumora Therapeutics Inc Insider Transactions

No Available Data

Joshua Pinto Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua Pinto. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Joshua Pinto's mailing address is: Watertown Ma 02472.